Literature DB >> 3102075

Clonal analysis of human tumor infiltrating lymphocytes reactive with autologous tumor cells: different target cell specificities of NK-like and cytotoxic T-cell clones.

H Rabinowich, Z Steiner, A Klajman.   

Abstract

Lymphocytes, derived from surgically resected lung carcinoid tissue, were stimulated in mixed culture with irradiated autologous tumor cells (MLTC). The autologous MLTC-stimulated lymphocytes were found to have killing activity against both autologous tumor cells and NK-sensitive target cells. The lymphoblasts generated during MLTC were isolated and cloned under limiting dilution conditions in the presence of interleukin 2. The cloned cell lines were analyzed for cell phenotype and tested for cytotoxic activity. Three cloned cell lines, out of 19 tested, were found to be cytotoxic either against NK-sensitive target cells (natural killers) or the autologous tumor cells. Two clones, having OKT8 phenotype, caused no lysis of the autologous tumor cells, though both exerted NK-like activity against K562 cells. Only one clone with OKT4 phenotype showed specific cytotoxic activity against the autologous tumor, but no NK-like activity against a panel of tumor target cells. These results suggest the coexistence of two types of antitumor cytotoxic lymphocytes at the tumor site: precursors of NK-like cells and specific cytotoxic T cells. Target cell specificity provided a means of distinguishing between the two types.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3102075     DOI: 10.1016/0008-8749(87)90023-2

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Appearance of the T-cell marker CD8 on B chronic lymphatic leukemia cells in long-term cultures.

Authors:  R Farkas; S Ben-Efraim; Y Manor; I Zan-Bar; A Klajman
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Alteration in interactions between tumor-infiltrating lymphocytes and tumor cells in human melanomas after chemotherapy or immunotherapy.

Authors:  K Itoh; K Hayakawa; M A Salmeron; S S Legha; J L Murray; M Talpaz; C M Balch; D R Parkinson; K Lee; A A Zukiwski
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  High endothelial venule and immunocompetent cells in typical medullary carcinoma of the breast.

Authors:  H Tanaka; M Hori; T Ohki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

4.  Tumor infiltrating lymphocytes of spontaneous versus transplanted mouse mammary tumors.

Authors:  W Z Wei; G H Heppner
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Expression and prognostic significance of HLA class I, ICAM-1, and tumor-infiltrating lymphocytes in esophageal cancer.

Authors:  S B Hosch; A J Meyer; C Schneider; N Stoecklein; K L Prenzel; K Pantel; C E Broelsch; J R Izbicki
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

6.  Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies.

Authors:  A Gorter; K M Krüse; P I Schrier; G J Fleuren; R J van de Griend
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

7.  Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluid.

Authors:  A Belldegrun; A Kasid; M Uppenkamp; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  Perforin expression in lymphocytes infiltrated to human colorectal cancer.

Authors:  H Nakanishi; T Monden; H Morimoto; T Kobayashi; T Shimano; T Mori
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.